Alembic Pharmaceuticals Limited — Others, 02-06-2025: Confirmation of Redemption/Payment of Interest and Principal

The company has confirmed the redemption/payment of interest and principal for its outstanding debt instruments as scheduled. This ensures timely fulfillment of its financial obligations, maintaining investor confidence and supporting its creditworthiness. Such actions reflect the company’s commitment to disciplined debt servicing, which is positive for stakeholders concerned about the firm’s financial stability and credibility in debt markets.